Tewari KS - Search Results

1

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.

Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS. Coleman RL, et al. Among authors: tewari ks. Lancet Oncol. 2017 Jun;18(6):779-791. doi: 10.1016/S1470-2045(17)30279-6. Epub 2017 Apr 21. Lancet Oncol. 2017. PMID: 28438473 Free PMC article. Clinical Trial.

2

Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgery.

Monk BJ, Walker JL, Tewari K, Ramsinghani NS, Nisar Syed AM, DiSaia PJ. Monk BJ, et al. Gynecol Oncol. 1994 Feb;52(2):222-8. doi: 10.1006/gyno.1994.1035. Gynecol Oncol. 1994. PMID: 8314143

3

Hexamethylmelamine as a single second-line agent in ovarian cancer: follow-up report and review of the literature.

Manetta A, Tewari K, Podczaski ES. Manetta A, et al. Gynecol Oncol. 1997 Jul;66(1):20-6. doi: 10.1006/gyno.1997.4725. Gynecol Oncol. 1997. PMID: 9234915 Review.

4

Advanced-stage small cell carcinoma of the ovary in pregnancy: long-term survival after surgical debulking and multiagent chemotherapy.

Tewari K, Brewer C, Cappuccini F, Macri C, Rogers LW, Berman ML. Tewari K, et al. Gynecol Oncol. 1997 Sep;66(3):531-4. doi: 10.1006/gyno.1997.4801. Gynecol Oncol. 1997. PMID: 9299272

5

Long-term consequences following conservative management of epithelial ovarian cancer in an infertile patient.

Moore MM, Tewari K, Rose GS, Fruehauf JP, DiSaia PJ. Moore MM, et al. Gynecol Oncol. 1999 Jun;73(3):452-4. doi: 10.1006/gyno.1999.5357. Gynecol Oncol. 1999. PMID: 10366478

6

Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women.

Chan JK, Lin YG, Monk BJ, Tewari K, Bloss JD, Berman ML. Chan JK, et al. Obstet Gynecol. 2001 May;97(5 Pt 1):707-11. Obstet Gynecol. 2001. PMID: 11339920

7

Recent advancements in the treatment of epithelial ovarian cancer.

DiSaia PJ, Tewari KS. DiSaia PJ, et al. Among authors: tewari ks. J Obstet Gynaecol Res. 2001 Apr;27(2):61-75. doi: 10.1111/j.1447-0756.2001.tb01223.x. J Obstet Gynaecol Res. 2001. PMID: 11396641 Review.

8

Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer.

Tewari KS, Monk BJ. Tewari KS, et al. Curr Oncol Rep. 2005 Nov;7(6):419-34. doi: 10.1007/s11912-005-0007-z. Curr Oncol Rep. 2005. PMID: 16221379 Review.

9

Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions.

Monk BJ, Tewari KS, Koh WJ. Monk BJ, et al. Among authors: tewari ks. J Clin Oncol. 2007 Jul 10;25(20):2952-65. doi: 10.1200/JCO.2007.10.8324. J Clin Oncol. 2007. PMID: 17617527 Review.

10

The influence of conservative surgical practices for malignant ovarian germ cell tumors.

Chan JK, Tewari KS, Waller S, Cheung MK, Shin JY, Osann K, Kapp DS. Chan JK, et al. Among authors: tewari ks. J Surg Oncol. 2008 Aug 1;98(2):111-6. doi: 10.1002/jso.21079. J Surg Oncol. 2008. PMID: 18563734 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page